Co-founder of NewLimit, developing epigenetic reprogramming medicines to reset aged cells; background in aging biology research since teenage years.
no scored calls yet — needs a stated position or a categorical verdict, with a matured window vs SPY
AI-driven discovery of transcription factor combinations resets epigenetic age in multiple cell types, with a first pre-clinical candidate targeting liver disease and pipeline expanding to T cells and vasculature.